Pneumeric, Inc. has partnered with JP Pharma to distribute the Capnospot® Pneumothorax Decompression Indicator in Brazil. This agreement enables emergency responders to utilize a device that offers visual confirmation of needle placement, enhancing life-saving interventions. JP Pharma’s extensive experience in tactical medical supplies aligns with Pneumeric’s mission to innovate in pre-hospital care.
Pneumeric, Inc. has established a distribution agreement with JP Pharma, allowing the Capnospot® Pneumothorax Decompression Indicator to be available to emergency responders in Brazil. This innovative device offers visual confirmation of proper needle placement through an easy color change, facilitating timely life-saving interventions. The collaboration with JP Pharma, a prominent tactical medical supplier in Latin America, aligns with both companies’ goals to enhance healthcare solutions in the region.
JP Pharma, known for representing top international medical device manufacturers, sees the integration of the Capnospot® as a significant addition to its product line. According to Bruno Tavora, JP Pharma’s Chief Operating Officer, this partnership reflects a mutual commitment to innovation in pre-hospital care, with the hope of saving more lives in Brazil.
Deon Miller, Chief Commercial Officer of Pneumeric, expressed confidence in the partnership, emphasizing the technological advancements Capnospot® brings to the marketplace. The device is specifically designed to improve the accuracy and effectiveness of tension pneumothorax decompression procedures, enhancing decision-making for first responders.
Founded in 2021, Pneumeric, Inc. aims to improve standards in tension pneumothorax care, supported by FDA clearance and patented technology for the Capnospot®. JP Pharma, established in 2008, focuses on equipping Brazil with high-quality medical products through strategic partnerships. More information about both companies can be found on their respective websites.
Pneumeric, Inc.’s collaboration with JP Pharma marks a significant step towards enhancing emergency medical responses in Brazil through the distribution of the Capnospot® device. This agreement underscores a shared commitment to innovation and improving healthcare outcomes, illustrating both companies’ dedication to advancing medical technology in the region. With the potential to save lives, the Capnospot® serves as a crucial tool for medical responders dealing with tension pneumothorax. As both parties continue to strengthen their partnership, the Brazilian market can expect improved medical practices and life-saving technologies.
Original Source: www.prweb.com
